Search for: "Grant v. Bristol-Myers Squibb" Results 21 - 40 of 140
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
19 Jan 2017, 1:07 pm by Amy Howe
Today’s grant comes in Bristol-Myers Squibb Co. v. [read post]
19 Jun 2017, 1:33 pm by Andrew Hamm
North Carolina. 2:56 p.m.: Ronald Mann analyzed the court’s opinion in Bristol-Myers Squibb Co. v. [read post]
18 Jul 2012, 4:34 pm by war
Both judgments, however, explicitly refused to re-open the question following Rescare and Bristol-Myers Squibb in light of long standing practice and Parliament’s lmitation of the exclusion from patentability in s 18(2) to humans and the biological processes for their generation. [read post]
24 Dec 2024, 4:40 am by Eveline Lots (Brinkhof)
On 30 October 2024, the District Court of the Hague handed down two merits decisions on the widely litigated apixaban patent of Bristol-Myers Squibb (see here and here – Dutch language versions). [read post]
10 Aug 2016, 2:40 pm by Michael Grossman
Created by the Japanese company Otsuka Pharmaceutical, it is marketed in North America by Otsuka America and their partner company Bristol Myers-Squibb, an enormous biopharmaceutical manufacturer/marketer. [read post]
26 Jun 2015, 11:30 am
  For whatever reason, California courts have seemed open to hosting plaintiffs from everywhere, a point well exemplified by our Hotel California post discussing the now-vacated Bristol-Myers Squibb Co. v. [read post]
Following the passage of the bylaw deadline, Icahn sought to nominate candidates for election to Amylin's board of directors in the wake of his learning of Amylin's recent rejection of an unsolicited takeover proposal by Bristol-Myers Squibb Co. [read post]
18 Nov 2014, 9:44 pm by Lawrence B. Ebert
” from a post by Kelly Laycock.The logic and style of the arguments about patent examiners is indeed incomprehensible.Perhaps "patenthawk" should include law review articles, in addition to court decisions, within his scope; from a recent post on Bristol-Myers Squibb v. [read post]
26 May 2007, 11:26 pm
Bristol-Myers Squibb and Sa nofi-Aventis, which co-market the widely used drug, defended the patent from a challenge by Canadian generic drugmaker Apotex, which briefly flooded the market with copycat Plavix tablets last summer. [read post]
24 Mar 2011, 1:12 pm by FDABlog HPM
Bristol-Myers Squibb, Inc., the employees claim that BMS paid kickbacks to physicians and pharmacists to increase prescriptions and dispensing of the company’s drugs. [read post]
28 Sep 2010, 3:14 pm by Kelly
Par Pharmaceutical Companies, Inc. et al (Patent Docs) Baraclude (Entecavir) – US: Patent infringement complaint filed following Paragraph IV certification: Bristol-Myers Squibb Co. v. [read post]
29 Jul 2013, 2:24 am
 Unfortunately,without any thumbs, he was unable to forwardthem to the true recipient, Bristol-Myers Squibb When the parties engaged in correspondence, Teva refused to divulge its launch plans as it considered these plans confidential. [read post]